Pulmonary Adenomatosis

Pulmonary adenomatosis is a condition where the tiny air sacs (alveoli) in your lungs fill up with thick mucus. This can make it hard to breathe. It's a non-cancerous (benign) condition, but it can cause symptoms like coughing up lots of thick phlegm, fever, and shortness of breath. It's often linked to other lung diseases.

Condition

What people with Pulmonary Adenomatosis report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Pulmonary Adenomatosis

What It Is

Pulmonary adenomatosis is an older name for a type of lung cancer in which tumor cells grow along the lining of the lung's tiny air sacs and produce large amounts of mucus. Doctors now call this mucus-producing cancer invasive mucinous adenocarcinoma, and older records may use the former name mucinous bronchioloalveolar carcinoma. It is an uncommon subtype of adenocarcinoma, the most frequent kind of lung cancer, and makes up roughly 3 to 10 percent of lung adenocarcinomas. The disease usually starts quietly. Many people have only a mild, lingering cough, and some cough up large amounts of clear or white mucus. On a scan it most often appears as a single spot in the lung, but it can also look like a patch of pneumonia spread through part of one or both lungs. That pneumonia-like pattern is one reason it matters: it is easily mistaken for an infection, which can delay the correct diagnosis.

Causes & Risk Factors

Researchers do not know what causes invasive mucinous adenocarcinoma. It is less strongly tied to smoking than most lung cancers, and a substantial share of people who develop it have never smoked or smoked very little. Smoking remains the most important risk factor for lung cancer overall, but a person with this diagnosis should not assume their habits caused it. Most people are middle-aged or older when it is found, and it is slightly more common in women. Most of these tumors carry a change in a gene called KRAS, which matters mainly for treatment choices. Whether exposures such as radon, asbestos or air pollution, a family history, or earlier lung damage play a role is not yet clear.

How It's Diagnosed

Diagnosis usually begins with a chest X-ray or a CT (computed tomography) scan, often done because of a cough or for another reason. On CT, the disease may look like a single nodule or mass, most often in a lower part of the lung, or like the dense, patchy shadowing of pneumonia. In the pneumonia-like form, people are often treated with antibiotics first. Clues that point away from infection include little or no fever and an abnormal area that does not clear, comes back in the same place, or slowly enlarges. Comparing scans over time helps make that distinction. Confirming the diagnosis requires a tissue sample (a biopsy), taken with a needle guided by CT, through a bronchoscope (a thin tube passed into the airways), or sometimes during surgery. Because these tumors contain a lot of mucus and relatively few cells, small samples can come back inconclusive, and a repeat or larger biopsy may be needed. A PET scan, which shows how actively tissues take up sugar, helps with staging, but these tumors often show only a faint signal, so a weak PET result does not rule the cancer out. Once cancer is confirmed, staging tests show whether it has spread within the lungs, to lymph nodes or elsewhere in the body. The tissue should also be tested for gene changes (biomarker testing), because a few specific changes have matching targeted treatments.

Treatment Options

Treatment depends mainly on whether the cancer is confined to an area that can be removed. For a single, localized tumor, surgery is the preferred treatment and often gives good long-term results. A small tumor near the edge of the lung may be removed with a smaller operation than taking out a whole lobe, depending on its size and position. When the disease is spread through several areas of one or both lungs, as in the pneumonia-like form, surgery may not be able to remove every focus, and the decision is made case by case, weighing how much lung function would remain. For advanced disease, treatment follows the general approach for non-small cell lung cancer, with real limits. Platinum-based chemotherapy shrinks the cancer in only about one in four people in published series, and immunotherapy (medicines that help the immune system attack cancer) appears to work less well than in other lung adenocarcinomas, though the studies are small. Radiation is mainly used to relieve symptoms or treat a specific area. Biomarker results can open other options. Sotorasib (Lumakras) and adagrasib (Krazati) are pills that block one particular KRAS change, called G12C, and are approved for advanced lung cancer with that change after earlier treatment; however, G12C is present in only a small share of these tumors. Zenocutuzumab (Bizengri), an antibody given by intravenous infusion, is approved for advanced lung cancer with an NRG1 gene fusion after earlier treatment, a change found more often in this subtype than in other lung cancers. Rarer changes, such as in EGFR or ALK, have their own targeted medicines. Because no standard treatment has been established specifically for this subtype, clinical trials are worth asking about. Palliative care, which focuses on comfort and symptoms, can be added at any stage to help with cough, heavy mucus and breathlessness.

What to Expect

The outlook differs sharply between the two main patterns. When a single tumor is found early and removed, outcomes are generally favorable, similar to or better than other lung adenocarcinomas of the same stage, and rare very small, minimally invasive forms are almost always cured by complete removal. When the disease is spread widely through the lungs or beyond, it can progress quickly and is much harder to control. This cancer has a tendency to come back, often elsewhere in the lungs, so follow-up after treatment relies on repeat chest imaging on a schedule set with the care team. For people living with advanced disease, daily life is often shaped by cough, large amounts of mucus and shortness of breath, and managing those symptoms becomes a central part of care alongside cancer treatment.

When to Seek Help

See a doctor about a cough that does not go away or keeps getting worse, especially if you are bringing up large amounts of clear or white mucus. If you were treated for pneumonia and a follow-up scan still shows the abnormal area, or it returns in the same place, ask whether further tests such as a CT scan or biopsy are needed rather than another course of antibiotics alone. If you are being treated for this cancer, contact your care team promptly about new or worsening shortness of breath, streaks of blood in your mucus, or a clear increase in the amount of mucus. Get emergency care for severe shortness of breath or for coughing up more than a few teaspoons of blood.

Questions to Ask Your Doctor

  1. 1.Is my cancer a single localized tumor, or is it spread through more than one part of my lungs, and how does that change my options?
  2. 2.Could surgery remove all of the cancer, and how much lung function would I have afterward?
  3. 3.Has my tumor been tested for gene changes such as KRAS G12C or an NRG1 fusion, and do any results point to a targeted treatment or clinical trial?
  4. 4.What follow-up scans will I need, and what signs of the cancer returning should I watch for?
  5. 5.What can help control the cough and heavy mucus?

Last reviewed • Oct 2026

Educational content, not medical advice.